Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Green tea for DCIS chemoprevention
NCT01060345Phase 2Terminated
- Sponsor
- University of Chicago
- Start
- May 2010
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of green tea extract in ductal carcinoma in situ (DCIS), sponsored by University of Chicago. Primary endpoint: Percent Change in Ki67 Staining. Started May 2010; status: terminated.
02
Drugs
green tea extract
03
Conditions
ductal carcinoma in situ (DCIS)
Beyond the preview
Go deeper on NCT01060345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060345.